It is a safe, effective, and minimally invasive treatment method that has many advantages for patients:
Across the HCG network, we carry some of the most advanced radiation therapy platforms that help us treat a broad spectrum of malignancies with excellent success rates.
CyberKnife is the world’s first whole-body robotic radiosurgery platform that can be used to treat multiple cancerous and non-cancerous conditions, namely prostate cancer, brain cancer, lung cancer, spine cancer, trigeminal neuralgia, etc. The radiation is delivered from multiple angles to precisely kill the cancer cells while sparing the surrounding healthy tissues. CyberKnife utilises real-time imaging to track even the smallest changes in tumour location caused by breathing or other bodily movements, allowing for precise and accurate radiation delivery to the target area while minimising damage to surrounding healthy tissues.
Ethos Adaptive Radiation Therapy is a radiation therapy platform that combines artificial intelligence (AI) with traditional adaptive therapy to capture and analyse fine-grained images, determine the kind, size, and location of tumours, and plan and deliver adaptive treatment within just 15 minutes. The platform allows radiation oncologists to study the anatomical changes before each session and alter the radiation treatment accordingly. Ethos Adaptive Radiation Therapy primarily aims at targeting the tumour more precisely, reducing the dose to surrounding healthy tissues, and improving the quality of overall treatment results.
TomoTherapy H is an advanced radiation delivery system that combines the benefits of computed tomography (CT scan) and a linear accelerator. It enables specialists to plan the treatment accurately and deliver high-dose radiation precisely to the target area, thanks to its real-time imaging guidance. With the ability to deliver up to 1000 beams of radiation from various angles, TomoTherapy H effectively destroys cancer cells. As a non-invasive procedure, it eliminates the risk of blood loss, prolonged hospital stays, and extended recovery. Patients can resume their day-to-day activities while undergoing treatment.
TrueBeam is another unique radiotherapy platform that precisely delivers radiation beams to destroy the tumour cells throughout the body while minimising damage to the surrounding healthy tissues. TrueBeam's advanced imaging facility and treatment models allow the specialists to customise radiation delivery for each cancer case. It synchronises radiation delivery with imaging and thereby adjusts radiation delivery according to the smallest movements shown by the patient, including breathing. TrueBeam can deliver high-dose radiation in a shorter duration, and this allows the specialists to shorten the overall treatment duration for the patients.
Versa HD is an all-in-one radiation delivery system that delivers radiation with advanced stereotactic precision. Versa HD comes with sophisticated conformal beam-shaping technology and high dose rate mode delivery, which improves the precision and facilitates the speed necessary to deliver stereotactic radiotherapy (SRT) and stereotactic radiosurgery (SRS) techniques, which require superior accuracy in tumour targeting and protecting the internal organs.
Brachytherapy, or internal beam radiation therapy, allows specialists to treat cancers by placing a radiation source inside or close to the tumour. The radiation emitted by this source kills the cancer cells over time. This helps deliver high-dose radiation to the target while sparing the healthy tissues surrounding the tumour. Brachytherapy is used to treat a wide range of cancers, namely prostate cancer, bladder cancer, cervical cancer, vaginal cancer, rectum cancer, head and neck cancer, skin cancer, breast cancer, gallbladder cancer, uterine cancer, and eye cancer.
Hyperthermia is a treatment approach wherein the cancer cells are exposed to heat up to 42°C. Usually, hyperthermia is administered in combination with radiation therapy or anti-cancer drugs. Hyperthermia is helpful in treating tumours on the skin, tumours of the head and neck region that may have spread to the lymph nodes, etc.